Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $35.6700 (-3.42%) ($35.6400 - $35.6700) on Thu. Dec. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.48% (three month average) | RSI | 56 | Latest Price | $35.6700(-3.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.2% a day on average for past five trading days. | Weekly Trend | HALO advances 3.7% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(52%) IWO(48%) IWM(47%) IWC(44%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.24% in a week (0% probabilities). VIXM(-27%) UUP(-11%) VXX(-10%) TBT(-3%) GLD(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.24% (StdDev 2.48%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.29(1.08%) | 10 Day Moving Average | $33.99(4.94%) | 20 Day Moving Average | $34.06(4.73%) | To recent high | -15.4% | To recent low | 12.1% | Market Cap | $4.875b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |